Older CGMs require long warm-up times. The NIH reports that continuous monitoring reduces severe events.

What’s happening

The Dexcom G7’s warm-up dropped from 2 hours to about 8 minutes—removing a risky window. Sally noticed instantly:

“From two hours to about eight minutes before I got my first reading.”
— Sally Figueroa

What you can do

• Upgrade if covered by insurance
• Compare pharmacy vs DME pricing
• Keep backup sensors to avoid downtime

What to avoid

• Being without readings for extended periods
• Assuming all CGMs warm up the same

How to move forward

Faster readings mean safer decision-making.

Our Pay It Forward Approach

Every small act of sharing creates a ripple. If this piece resonated with you, consider sending it to someone who might need the same hope today—or leave us a comment in the section below with your own saving story so thousands can benefit from it. No one should have to navigate the cost of illness alone.

Verification Note

Checked and verified active December, 2025.
All sources are peer-reviewed, government, nonprofit, or FDA-regulated primary sources directly supporting safety, clinical, and device-performance claims referenced in this article.

Continuous glucose monitoring and reduction of severe events

National Institutes of Health (NIH) / PubMed Central — Continuous Glucose Monitoring and Severe Hypoglycemia Outcomes
Peer-reviewed systematic review confirming that CGM use significantly reduces severe hypoglycemia events and improves safety for insulin-treated patients.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397018/

Centers for Disease Control and Prevention (CDC) — Diabetes Technology and Monitoring
Federal guidance recognizing CGMs as key tools in preventing acute glucose emergencies.
https://www.cdc.gov/diabetes/managing/devices.html

Dexcom G7 warm-up time and device performance

U.S. Food & Drug Administration (FDA) — Dexcom G7 Continuous Glucose Monitoring System Approval Documentation
FDA device summary confirming Dexcom G7 performance characteristics, including shortened warm-up time compared with prior models.
https://www.accessdata.fda.gov/cdrh_docs/reviews/K221825.pdf

Dexcom — Dexcom G7 User Guide (Warm-Up and Startup Specifications)
Manufacturer documentation stating an approximately 8-minute warm-up period before first glucose readings are available.
https://www.dexcom.com/g7/how-it-works

Risk associated with CGM downtime and delayed readings

Journal of Diabetes Science and Technology — CGM Interruption and Hypoglycemia Risk
Peer-reviewed analysis demonstrating that gaps in CGM data increase the risk of delayed response to glucose excursions.
https://journals.sagepub.com/doi/10.1177/1932296819891304

American Diabetes Association (ADA) — Diabetes Technology: CGMs
ADA guidance emphasizing continuous data availability as a core safety feature of CGM use.
https://diabetes.org/diabetes/technology/continuous-glucose-monitors-cgms

Insurance coverage pathways and access considerations

Centers for Medicare & Medicaid Services (CMS) — Continuous Glucose Monitors Coverage Policy
Federal policy explaining CGM coverage under pharmacy and Durable Medical Equipment (DME) pathways.
https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?LCDId=33822

Patient Advocate Foundation — Accessing Diabetes Technology
Nonprofit guidance on navigating insurance coverage, replacements, and appeals for CGM systems.
https://www.patientadvocate.org/explore-our-resources/chronic-illness/diabetes/